Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Gross Margin: 2009-2025

Historic Gross Margin for Northwest Biotherapeutics (NWBO) over the last 17 years, with Sep 2025 value amounting to 100.00%.

  • Northwest Biotherapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Per Northwest Biotherapeutics' latest filing, its Gross Margin stood at 100.00% for Q3 2025, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Northwest Biotherapeutics' 5-year Gross Margin high stood at 100.00% for Q1 2021, and its period low was 100.00% during Q1 2021.
  • Over the past 3 years, Northwest Biotherapeutics' median Gross Margin value was 100.00% (recorded in 2025), while the average stood at 100.00%.